Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06758622Active Not Recruiting

Analysis on the Health of Newborns in Three Hospitals, 2008-2024

Role: collaborator

NCT06653374Completed

Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns

Role: collaborator

NCT04999774Completed

Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study

Role: collaborator

NCT05387174Not ApplicableCompleted

Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period

Role: collaborator

NCT05373550Not ApplicableUnknown

Effectiveness of a Nursing Intervention on Quality of Life, Sexual Function, and Self-esteem in Hysterectomized Women

Role: collaborator

NCT01971112Not ApplicableUnknown

Nutritional Intervention and Respiratory Infections in Older Subjects

Role: collaborator

NCT00300937Phase 3Completed

Coenzyme Q10 Supplementation and Development of Preeclampsia

Role: collaborator

All 7 trials loaded